GD-iExo-001
/ Guidon Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 01, 2023
Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis
(clinicaltrials.gov)
- P1 | N=20 | Recruiting | Sponsor: Peking Union Medical College Hospital
New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 1
Of
1
Go to page
1